These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33887)

  • 21. [Comparison of the methods of in vitro evaluation of the neutralizing properties of drugs from the antacid group].
    Pawlaczyk J; Kokot Z; Urbowicz G; Ewertowska D
    Acta Pol Pharm; 1989; 46(3):272-9. PubMed ID: 2618772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of rebound effect with calcium carbonate.
    Simoneau G
    Eur J Drug Metab Pharmacokinet; 1996; 21(4):351-7. PubMed ID: 9074901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
    Prieto R; Martinez-Tobed A; Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1360-4. PubMed ID: 6548920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
    Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
    Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dosage alternative for H2-receptor antagonists--constant infusion.
    Siepler JK
    Clin Ther; 1986; 8 Suppl A():24-33. PubMed ID: 2878728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antacid on gastric and duodenal bulb acidity.
    Hannibal S; Remvig L; Rune SJ
    Scand J Gastroenterol Suppl; 1980; 58():29-36. PubMed ID: 6929092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antacid therapy and the gastric mucosal barrier.
    Dill JE
    Gastroenterology; 1972 Apr; 62(4):697. PubMed ID: 5020882
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined 24-hour intraluminal pH and bile monitoring of the denervated whole stomach as an esophageal substitute.
    Romagnoli R; Bechi P; Salizzoni M; Collard JM
    Hepatogastroenterology; 1999; 46(25):86-91. PubMed ID: 10228769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fate of oral neutralizing antacid and its effect on postprandial gastric secretion and emptying.
    Deering TB; Carlson GL; Malagelada JR; Duenes JA; McCall JT
    Gastroenterology; 1979 Nov; 77(5):986-90. PubMed ID: 39873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro studies on antacids/Third communication (author's transl)].
    Schnekenburger J
    Arzneimittelforschung; 1981; 31(8):1286-90. PubMed ID: 6271146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.
    Sulz MC; Manz M; Grob P; Meier R; Drewe J; Beglinger C
    Digestion; 2007; 75(2-3):69-73. PubMed ID: 17496418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intragastric pH measurements for the evaluation of the new antacid Simagel].
    Bergmann M
    Dtsch Z Verdau Stoffwechselkr; 1966 Sep; 26(2):70-4. PubMed ID: 5996881
    [No Abstract]   [Full Text] [Related]  

  • 33. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
    Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
    Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acetlysalicylic acid, protective antacid effect and lesions of the gastric mucosa. Effect of acetylsalicylic acid and an antacid drug (Gastropulgit Tabs) on the transmural electric potential in the human stomach].
    Caspary WF; Kausch H
    Fortschr Med; 1979 Aug; 97(30-31):1333-6. PubMed ID: 468096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin injury to the gastric mucosa. Gastrocamera observations of the effect of pH.
    Thorsen WB; Western D; Tanaka Y; Morrissey JF
    Arch Intern Med; 1968 Jun; 121(6):499-506. PubMed ID: 4870934
    [No Abstract]   [Full Text] [Related]  

  • 36. [Method for determining the acid-reducing capacity of antacid preparations].
    Chakŭrski I; Dobrev Kh; Dobreva P
    Vutr Boles; 1986; 25(6):33-5. PubMed ID: 3564432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intragastric pH increase using antacids or secretin for stress ulcer prevention in surgical risk patients].
    Lehmann L; Düsel W; Pfeiffer H; Rietbrock I
    Chirurg; 1984 Jul; 55(7):455-60. PubMed ID: 6380982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of prolonged antacid administration on rat gastric mucosa.
    Koop H; Spill W; Schwarting H; Arnold R
    Z Gastroenterol; 1988 Oct; 26(10):643-7. PubMed ID: 3144098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of various techniques to monitor intragastric pH.
    Meiners D; Clift S; Kaminski D
    Arch Surg; 1982 Mar; 117(3):288-91. PubMed ID: 6978120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro study of the neutralizing effect of the most frequently used antacids].
    Matincheva R; Antonov P; Kiratsov E
    Vutr Boles; 1983; 22(5):43-7. PubMed ID: 6689508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.